Alex W. Tong

1.5k total citations
26 papers, 1.2k citations indexed

About

Alex W. Tong is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Alex W. Tong has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Genetics and 8 papers in Oncology. Recurrent topics in Alex W. Tong's work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (6 papers) and Cancer Research and Treatments (4 papers). Alex W. Tong is often cited by papers focused on Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (6 papers) and Cancer Research and Treatments (4 papers). Alex W. Tong collaborates with scholars based in United States, Spain and Japan. Alex W. Tong's co-authors include John Nemunaitis, Marvin J. Stone, Yuan Zhang, Patrick Chen, Chris Jay, Pat F. Fulgham, Neil Senzer, Anagha P. Phadke, Phillip B. Maples and Beena O. Pappen and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Clinical Cancer Research.

In The Last Decade

Alex W. Tong

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alex W. Tong United States 16 644 464 448 298 221 26 1.2k
Kunjlata M. Amin United States 23 649 1.0× 688 1.5× 417 0.9× 243 0.8× 62 0.3× 28 1.6k
Robert I. Garver United States 24 852 1.3× 514 1.1× 450 1.0× 88 0.3× 197 0.9× 30 1.5k
Béatrice Quantin France 7 813 1.3× 451 1.0× 401 0.9× 142 0.5× 437 2.0× 8 1.4k
Maaret Ridanpää Finland 17 809 1.3× 208 0.4× 449 1.0× 381 1.3× 266 1.2× 28 1.5k
Kiyoko Kawamura Japan 22 547 0.8× 244 0.5× 522 1.2× 672 2.3× 169 0.8× 46 1.3k
Sorin Armeanu Germany 19 880 1.4× 227 0.5× 289 0.6× 403 1.4× 105 0.5× 38 1.4k
D Bautista Canada 7 600 0.9× 396 0.9× 268 0.6× 99 0.3× 111 0.5× 8 1.0k
Sima J. Zacharek United States 13 821 1.3× 161 0.3× 320 0.7× 387 1.3× 123 0.6× 16 1.2k
Stefan Störkel Germany 16 429 0.7× 125 0.3× 379 0.8× 539 1.8× 192 0.9× 30 1.2k
Laura K. Aguilar United States 22 444 0.7× 512 1.1× 791 1.8× 537 1.8× 75 0.3× 45 1.5k

Countries citing papers authored by Alex W. Tong

Since Specialization
Citations

This map shows the geographic impact of Alex W. Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex W. Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex W. Tong more than expected).

Fields of papers citing papers by Alex W. Tong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alex W. Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex W. Tong. The network helps show where Alex W. Tong may publish in the future.

Co-authorship network of co-authors of Alex W. Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Alex W. Tong. A scholar is included among the top collaborators of Alex W. Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alex W. Tong. Alex W. Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Catherine, Alex W. Tong, Mariam Mir, & Yvonne M. Coyle. (2015). Lobular Carcinoma of the Breast with Gastrointestinal Metastasis. Baylor University Medical Center Proceedings. 28(1). 50–53. 6 indexed citations
2.
Jones, Catherine, Yair Levy, & Alex W. Tong. (2014). Elevated serum erythropoietin in a patient with polycythaemia vera presenting with Budd-Chiari syndrome. BMJ Case Reports. 2014. bcr2014205663–bcr2014205663. 11 indexed citations
3.
Tong, Alex W., Neil Senzer, Vincenzo Cerullo, et al.. (2012). Oncolytic Viruses for Induction of Anti-Tumor Immunity. Current Pharmaceutical Biotechnology. 13(9). 1750–1760. 57 indexed citations
4.
Nemunaitis, Gregory, Chris Jay, Phillip B. Maples, et al.. (2011). Hereditary Inclusion Body Myopathy: Single Patient Response to Intravenous Dosing of GNE Gene Lipoplex. Human Gene Therapy. 22(11). 1331–1341. 36 indexed citations
5.
Nemunaitis, Gregory, Phillip B. Maples, Chris Jay, et al.. (2010). Hereditary inclusion body myopathy: single patient response to GNE gene Lipoplex therapy. The Journal of Gene Medicine. 12(5). 403–412. 19 indexed citations
6.
Gomes, Erica M., Lindsay D. Butcher, Joe Kansopon, et al.. (2009). Growth Inhibition of Human Multiple Myeloma Cells by an Oncolytic Adenovirus Carrying the CD40 Ligand Transgene. Clinical Cancer Research. 15(15). 4847–4856. 36 indexed citations
7.
Nemunaitis, John, Alex W. Tong, Michael Nemunaitis, et al.. (2009). A Phase I Study of Telomerase-specific Replication Competent Oncolytic Adenovirus (Telomelysin) for Various Solid Tumors. Molecular Therapy. 18(2). 429–434. 205 indexed citations
8.
Gomes, Erica M., Anagha P. Phadke, Lindsay D. Butcher, et al.. (2009). Antitumor Activity of an Oncolytic Adenoviral-CD40 Ligand (CD154) Transgene Construct in Human Breast Cancer Cells. Clinical Cancer Research. 15(4). 1317–1325. 55 indexed citations
9.
Jay, Chris, John Nemunaitis, Patrick Chen, Pat F. Fulgham, & Alex W. Tong. (2007). mi RNA Profiling for Diagnosis and Prognosis of Human Cancer. DNA and Cell Biology. 26(5). 293–300. 185 indexed citations
10.
Zhang, Yuan, et al.. (2006). Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA. Cancer Research. 66(19). 9736–9743. 62 indexed citations
11.
Konduri, Kartik, Surinder S. Sahota, Gavin Babbage, et al.. (2005). Immunoglobulin M Myeloma: Evaluation of Molecular Features and Cytokine Expression. Clinical Lymphoma. 5(4). 285–289. 3 indexed citations
12.
13.
Zhang, Yuan, John Nemunaitis, & Alex W. Tong. (2003). Anti-K- rasRibozyme Adenoviral Vector for Gene Therapy of Non-Small Cell Lung Cancer. Humana Press eBooks. 35. 261–271.
14.
Stone, Marvin J., et al.. (2003). Human monoclonal macroglobulins with antibody activity. Seminars in Oncology. 30(2). 318–324. 38 indexed citations
15.
Tong, Alex W. & Marvin J. Stone. (2002). Prospects for CD40-directed experimental therapy of human cancer. Cancer Gene Therapy. 10(1). 1–13. 143 indexed citations
16.
Tong, Alex W., Yuan Zhang, Casey Cunningham, Phillip B. Maples, & John Nemunaitis. (2001). Potential Clinical Application of Antioncogene Ribozymes for Human Lung Cancer. Clinical Lung Cancer. 2(3). 220–226. 8 indexed citations
17.
Zhang, Yuan, John Nemunaitis, & Alex W. Tong. (2000). Generation of a Ribozyme-Adenoviral Vector Against K-ras Mutant Human Lung Cancer Cells. Molecular Biotechnology. 15(1). 39–49. 15 indexed citations
18.
Tong, Alex W., et al.. (2000). CD40 Ligand-Induced Apoptosis is Fas-Independent in Human Multiple Myeloma Cells. Leukemia & lymphoma. 36(5-6). 543–558. 35 indexed citations
19.
Tong, Alex W. & Marvin J. Stone. (1996). CD40 and the Effect of Anti-CD40-Binding on Human Multiple Myeloma Clonogenicity. Leukemia & lymphoma. 21(1-2). 1–8. 25 indexed citations
20.
Tong, Alex W., et al.. (1983). Detection of antigen specific rosette formation with the FACS. Journal of Immunological Methods. 56(1). 63–74. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026